Opiant Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Opiant Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 49% to $40,725,185. The net income raised on $3,008,790 and profit margin reached 7%. Total operating expenses were $26,502,442.
Profit Margin
| 2012 | 0 | -12.42M | |
|---|---|---|---|
| 2013 | 0 | -4.65M | |
| 2014 | 0 | -11.48M | |
| 2015 | 1.55M | -7.03M | -454.06% |
| 2016 | 9.89M | -7.81M | -78.95% |
| 2017 | 18.44M | 6.58M | 35.68% |
| 2018 | 13.51M | -21.19M | -156.85% |
| 2019 | 38.23M | 11.59M | 30.32% |
| 2020 | 27.40M | -1.86M | -6.79% |
| 2021 | 40.72M | 3.00M | 7.39% |
OPNT Income Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 40.72M | 27.40M | 38.23M | 13.51M | 18.44M | 9.89M | 1.55M | 0 | 0 | 0 |
Cost of revenue | 9.06M | 6.19M | 7.72M | 1.49M | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 31.65M | 21.20M | 30.51M | 12.02M | 18.44M | 9.89M | 1.55M | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 16.83M | 9.24M | 9.07M | 8.47M | 3.17M | 1.74M | 2.41M | 464.60K | 282.67K | 506.16K |
Selling and marketing | 4.57M | 4.68M | 611.57K | 213.89K | 1.65M | 317.91K | 0 | 0 | 0 | 0 |
Total operating expenses | 26.50M | 23.44M | 19.60M | 33.21M | 11.35M | 17.63M | 8.44M | 11.30M | 4.28M | 12.33M |
Operating income | 5.15M | -2.24M | 10.91M | -21.19M | 7.09M | -7.73M | -6.89M | -11.30M | -4.28M | -12.33M |
Other income (expenses), net | -2.12M | -46.11K | 504.32K | -98.28K | 38.32K | -63.88K | -138.38K | -179.44K | 182.12K | -85.48K |
Income before tax | 3.03M | -2.28M | 11.41M | -21.14M | 7.13M | -7.81M | -7.03M | -11.48M | -4.65M | -12.42M |
Income tax expense | 24.27K | -425.67K | -177.23K | 51.28K | 550.47K | -51.99K | -81.91K | 141.15K | 735.17K | 0 |
Net income | 3.00M | -1.86M | 11.59M | -21.19M | 6.58M | -7.81M | -7.03M | -11.48M | -4.65M | -12.42M |
Earnings per share | ||||||||||
Basic EPS | 0.68 | -0.44 | 2.88 | -7.1 | 3.27 | -4.09 | -3.88 | -6.57 | -3.25 | -12 |
Diluted EPS | 0.51 | -0.44 | 2.17 | -7.1 | 2.94 | -4.09 | -3.88 | -6.57 | -3.25 | -12 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |